CAS NO: | 1643120-60-8 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | YZ129 is an inhibitor of the HSP90-calcineurin-NFAT pathway against glioblastoma, directly binding toheat shock protein90 (HSP90)with anIC50of 820 nM on NFAT nuclear translocation. YZ129-induced GBM cell-cycle arrest at the G2/M phase promotesapoptosisand inhibited tumor cell proliferation and migration[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
分子量 | 300.31 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C19H12N2O2 | ||||||||||||||||
CAS 号 | 1643120-60-8 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 5.6 mg/mL(18.65 mM;ultrasonic and warming and heat to 80℃) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |